(Q52197184)

26 April 2018

title

Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron. (English)

1 reference

26 April 2018

author name string

Suzuki T

1

1 reference

26 April 2018

Ise Y

2

1 reference

26 April 2018

Mori T

3

1 reference

26 April 2018

Misawa M

4

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

26 April 2018

published in

Life Sciences

1 reference

26 April 2018

volume

61

1 reference

26 April 2018

issue

16

1 reference

26 April 2018

page(s)

PL249-54

1 reference

26 April 2018

Symptoms of tobacco withdrawal. A replication and extension.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Effects of nicotine withdrawal on central dopaminergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Effects of nicotine on body weight and food consumption in female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

The use of place conditioning in studying the neuropharmacology of drug reinforcement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Mecamylamine-precipitated nicotine-withdrawal aversion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Drug interactions in the reinforcing effects of over-the-counter cough syrups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Animal models of drug withdrawal symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900745-5

10.1016/S0024-3205(97)00745-5

7 January 2021

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

9353175

1 reference

26 April 2018